Disparity in USA cataract surgery

Article

Medicare patients in the United States are 5.5 times more likely to get cataract surgery than those who receive their care from the Department of Veterans Affairs, according to a study reported in the March 2010 issue of the American Journal of Medical Quality

Medicare patients in the United States are 5.5 times more likely to get cataract surgery than those who receive their care from the Department of Veterans Affairs, according to a study reported in the March 2010 issue of the American Journal of Medical Quality.

This appears to endorse the trend that the frequency of cataract surgery may be responsive to financial incentives to either or both the medical facility and the doctors who conduct the surgery.

“We don't know yet what exactly accounts for the five and a half fold difference in surgery rates between the two systems. It may be related to how the two systems are funded by the government, it could be a difference between physician-driven decisions or it may be related to a lack of ophthalmologists within the VA system or it could be more than one of these factors,” said first author Dustin French, Ph.D., Regenstrief Institute investigator and assistant professor of medicine at the Indiana University School of Medicine. Dr French is a health economist who studies health outcomes.

“The results of our study raise important questions about the possible existence of a two-tier, federally funded health-care system that may not be equivalent in terms of quality of care,” said Dr French, who is also a research scientist with the Centre of Excellence on Implementing Evidence Based Practice at the Richard A. Roudebush VA Medical Centre.

The authors note that their findings provide ample reason to further investigate the determinants of cataract surgery rates. Nationwide, in America, cataract surgery is the most common surgical procedure performed by ophthalmologists.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.